Cytodyn Inc (CYDY)

[Saltz]

“I think we can see $2 as soon as we PR at least 10 enrollee's in cancer trial and BLA submitted. Once we are uplisted, this will increase quickly to $4-5 until approval.”

You left out BTD and that is a really big event in terms of immediatey increasing valuation. Many more eyeballs will be on CYDY because of the history relating to drugs that are granted BTD.

These are the dominoes that are positioned to fall:

BLA submission

Continued positive mTNBC Data on 5 plus patients

Green Light from FDA for BTD
$40-$50M Non Dilutive Deal

Those events will push the SP to the $3-$4 plus for uplist.

Nader can control two very important events in the short term.

1-BLA submission and making sure it is clean so the FDA accepts on the first pass.

2-Injecting as many qualified patients as possible for the nTNBC trial.

The data will be what it is - and we all know that the outcome for the next 5-10 patients is going to tell us just how big of a fish we have hooked. If it holds true to the first two patients Naders $40-$50M non dilutive deal is a cake walk and will lead to a SP that will allow for an organic uplist.

For anyone w half a clue to be selling at this juncture should have their head examined. This is like preparing your whole life for that putt to win a major championship and you bail because the moment is just too big to handle.

So much is riding on the data from the next 5-10 patients, it’s getting really hard to focus on anything else in my life.